X hits on this document

Powerpoint document

Considerations for Exposure to Diazinon and Chlorpyrifos - page 49 / 49

138 views

0 shares

0 downloads

0 comments

49 / 49

References from our laboratory, continued

.

Costa LG, Vitalone A, Cole TB and Furlong CE. 2005. Modulation of paraoxonase (PON1) activity. Biochemical Pharmacology 69(4):541-550.

Furlong CE, Cole TB, Walter BJ, Shih DM, Tward A, Lusis AJ, Timchalk C, Richter RJ, Costa LG.  Paraoxonase 1 (PON1) status and risk of insecticide exposure.  2005 J Biochem Toxicol 19:182-183.

Costa LG and CE Furlong.  Paraoxonase (PON1) gene polymorphisms. Encyclopedia Of Medical Genomics and Proteomics 2005; pp 965-969.  DOI: 10.1081/E-EDGP-120030804

Costa LG, Cole TB, Furlong CE. 2005. Paraoxonase (PON1): from toxicology to cardiovascular medicine.  Acta Biomed Suppl 2; 50-57.

C.E. Furlong.  2000.  PON1 Status and neurologic symptom complexes in Gulf War veterans.  Genome Research 10:153-155.

Costa LG, Cole TB, Vitalone A, Furlong CE. Paraoxonase (PON1) polymorphisms and toxicity of organophosphates. In: Toxicology of Organophosphates and Carbamate Pesticides. RC Gupta, ed. Elsevier Inc., San Diego, 2005. In press.

Furlong C, Holland N, Richter R, Bradman A, Ho A, and B Eskenazi. PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity.  In press: Pharmacogenetics and Genomics.

Document info
Document views138
Page views139
Page last viewedSat Dec 10 18:54:09 UTC 2016
Pages49
Paragraphs315
Words5623

Comments